wire - news in brief

« BACK

Pharmacology



Results 1 - 50 of 1689.
1 2 3 4 5 ... 34 Next »


Health - Pharmacology - 09.11.2022
Temporary mild damage to heart muscle cells after Covid-19 booster vaccination
Temporary mild damage to heart muscle cells after Covid-19 booster vaccination
An interdisciplinary research team from the University of Basel and the University Hospital Basel has studied the effects of the Covid-19 booster vaccination on the heart muscle.

Health - Pharmacology - 27.10.2022
Overcoming resistance to colon cancer treatment
Overcoming resistance to colon cancer treatment
A team from the UNIGE has found an alternative for patients who have developed resistance to chemotherapy treatments. Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs.

Pharmacology - Life Sciences - 21.09.2022

Health - Pharmacology - 10.06.2022

Health - Pharmacology - 08.06.2022
Major US award for Bern and Geneva researchers
Major US award for Bern and Geneva researchers
A prestigious grant from the USA goes to the biomedical scientist Sven Rottenberg, University of Bern, and the clinical scientist Intidhar Labidi-Galy, University of Geneva and University Hospital of Geneva.

Pharmacology - Health - 24.05.2022
Turning drug discovery into speed dating
Turning drug discovery into speed dating
EPFL spin-off ArcoScreen has developed a platform that turns the discovery of new drugs for Alzheimer's and Parkinson's disease, diabetes and cancer from a marathon into a sprint. The firm's microfluidic readout system assesses the response of G-protein-coupled receptors (GPCRs) to new substances, delivering significant time and financial gains for pharmaceutical companies.

Health - Pharmacology - 29.04.2022
Three Simple Interventions for Cancer Prevention in Older People
A combination of high-dose vitamin D, omega-3 fatty acids and a simple home strength exercise program (SHEP) can cumulatively reduce the risk of cancer in healthy adults over the age of 70 by 61 percent, the international DO-HEALTH study led by the University of Zurich has shown. It is the first study to test the combined benefit of three affordable public health interventions for the prevention of invasive cancers.

Health - Pharmacology - 21.03.2022
A novel painless and reliable allergy test
Although allergies are widespread, their diagnosis is complex and, depending on the type of allergy, the prospects of success with therapy are not always clear.

Pharmacology - Life Sciences - 16.03.2022
Swiss vaccine candidates enter clinical trial phase
Researchers from Bern, Geneva, Berlin and Riems are developing two vaccine candidates against SARS-CoV-2.

Health - Pharmacology - 07.03.2022
Overcoming resistance to breast cancer treatment
Overcoming resistance to breast cancer treatment
A team from the UNIGE has identified a potential target for restoring the efficacy of standard treatment in resistant patients. Many breast cancer patients develop resistance to standard drug treatments aimed at preventing the growth of cancer cells. A team from the University of Geneva has identified a molecular regulator involved in these resistance mechanisms.

Health - Pharmacology - 28.02.2022
Therapy for muscular dystrophy: A new start-up at the Biozentrum
Therapy for muscular dystrophy: A new start-up at the Biozentrum
Prof. Markus Rüegg and Dr. Judith Reinhard from the Biozentrum of the University of Basel have founded the start-up SEAL Therapeutics AG together with Dr. Thomas Meier, former CEO of Santhera Pharmaceuticals.

Health - Pharmacology - 10.02.2022
ANTICOV: Clinical Trial for COVID-19 in Low-resource Settings to Test a New Drug Combination
ANTICOV: Clinical Trial for COVID-19 in Low-resource Settings to Test a New Drug Combination
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.

Health - Pharmacology - 26.01.2022

Pharmacology - Life Sciences - 02.12.2021
Innovative research into new vaccines
Innovative research into new vaccines
Projects taking part in the National Research Programme "Covid-19" (NRP 78) of the Swiss National Science Foundation (SNSF) are pursuing highly promising approaches in a drive to develop new vaccines.

Pharmacology - Health - 29.11.2021

Environment - Pharmacology - 17.11.2021
World Toilet Day 2021: The toilet revolution is here
World Toilet Day 2021: The toilet revolution is here
In professional circles, there is talk of a toilet revolution. What exactly is going on here? It is not only about the toilet itself, but also highly about the treatment of excreta.

Pharmacology - Health - 09.11.2021
A first for Switzerland: proton therapy to treat lung cancer
A first for Switzerland: proton therapy to treat lung cancer
Today a 60-year-old patient suffering from lung cancer received proton beam therapy, a medical procedure where positively charged particles are precisely targeted at the tumour. This is the first time this type of radiotherapy has been used for lung cancer treatment in Switzerland. The 7-week course of treatment is part of an international clinical trial in which the PSI and cantonal hospitals in Aarau are taking part.

Health - Pharmacology - 25.10.2021
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research
The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine's pioneering leadership in genomic science.

Pharmacology - 20.10.2021
TB-PRACTECAL: Clinical Trial Yields Promising Results for Drug-Resistant Tuberculosis Treatment
TB-PRACTECAL, a clinical trial led by Médecins Sans Frontières with partners including Swiss TPH, has found that a new all-oral treatment regimen for rifampicin-resistant tuberculosis (RR-TB) is safer and more effective than the current accepted standard of care.

Pharmacology - Health - 14.10.2021
Roche’s Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma
Short duration infusion of Gazyvaro (obinutuzumab) is administered with a target infusion time of 90 minutes, compared to the current standard infusion time of approximately three to four hours Resul

Health - Pharmacology - 08.10.2021
Wyss Center announces new collaboration to improve brain tumor treatment
Wyss Center announces new collaboration to improve brain tumor treatment
Translational project will create the first detailed 3D maps of human glioblastomas with an integrated 'tissue time machine' to predict response to therapies Geneva, Switzerland - The Wyss Center ann

Pharmacology - Health - 07.10.2021
Novartis to present broad range of portfolio data at ECTRIMS, reinforcing long-standing commitment to people living with multiple sclerosis
Novartis will present 41 abstracts from a wide-ranging multiple sclerosis (MS) portfolio, including new data on Kesimpta (ofatumumab) and Mayzent (siponimod) Novartis will be commencing Phase III pivotal trials investigating remibrutinib in RMS.

Pharmacology - Health - 07.10.2021
Erster Malaria-Impfstoff von der WHO für Kinder empfohlen
Yesterday, the World Health Organization (WHO) recommended the widespread use of the malaria vaccine RTS,S/AS01, debuting a tool that could save the lives of tens of thousands of children in sub-Saharan Africa each year.

Pharmacology - Health - 01.10.2021

Pharmacology - Health - 30.09.2021
Novartis data show rapid and effective disease activity control with remibrutinib (LOU064) in patients with chronic spontaneous urticaria
Results from a Phase IIb study show all remibrutinib doses provided significant improvements in UAS7 change from baseline at week 4 and week 12 compared to placebo, and a favorable safety profile acr

Pharmacology - Health - 29.09.2021
Novartis data show achieving complete control of chronic spontaneous urticaria (CSU) improves overall quality of life, as reported by patients
Data analysis shows that preventing the symptoms of CSU (achieving complete control) improves overall health-related quality of life (HRQoL); including sleep and work productivity, among other measur

Pharmacology - Health - 29.09.2021
New data reinforce efficacy and convenience of Novartis Cosentyx (secukinumab) 300 mg autoinjector in adults with psoriasis
New findings show Cosentyx (secukinumab) 300 mg single dose autoinjector (the UnoReady pen) resulted in superior efficacy vs placebo 1 Patient satisfaction with 300 mg autoinjector was high - reachin

Pharmacology - Health - 29.09.2021
Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria
Novartis and Medicines for Malaria Venture (MMV) report positive Phase 2b study results for novel non-artemisinin combination to treat uncomplicated malaria In the Phase 2b study conducted in childre
1 2 3 4 5 ... 34 Next »